108
Participants
Start Date
April 20, 2017
Primary Completion Date
June 15, 2019
Study Completion Date
January 31, 2021
Atorvastatin 40 Mg Oral Tablet
patients followed up for 3 months
Rosuvastatin 20 Mg Oral Tablet
patients followed up for 3 months
Heart Institute, Cairo
Helwan University
OTHER